Articles

RSS

Catalent Pharma Solutions, one of the leading providers of advanced dose form and packaging technologies as well as development,manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies,was honored by The Procter & Gamble Company for its innovative DelPouch unit-dose delivery system. The advanced design, recognized for its consumer-friendly application, was awarded the "Special Recognition for Skincare Innovation 2006-2007" from P&G's External Business Development group.

The DelPouch unit-dose delivery system provides consumers with an easy to use, precise and sanitary means of applying lotions, creams and ointments. Instead of having to squeeze a tube onto hands or fingers, or to extract the contents of bottles, pouches or jars by hand, the DelPouch®system allows consumers to dispense and apply products in a single, sanitary step. Consumers simply squeeze a pouch attached to a foam pad that releases the contents directly onto the treatment area. Each pouch has a carefully measured amount of the required product, making the product easier to use, more precise and safer for the average consumer.

"At P&G, the consumer is boss," said Brad Trucksis, External Business Development, P&G. "Working with Catalent, P&G was able to rapidly deliver this product to market to help meet a consumer need – a way to apply Olay® Regenerist facial lotion without getting it on the hands. We look forward to working with Catalent in the future on other ways to help improve consumers' lives."

Catalent's patented-protected system is ideal for most topical products. Since only the foam pad comes in direct contact with the skin, it can prevent potential bacteria from a finger from ever touching the affected area.

"Catalent is proud to work with our partners to develop new designs and innovations that make their products easier to use while enhancing safety," said Tracy Tsuetaki, Group President, Packaging Services, Catalent. "Partnering with P&G has been extremely rewarding for Catalent, and we look forward to continuing our partnership well into the future."

About Catalent
Headquartered in Somerset, New Jersey, Catalent is one of the leading providers of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. The company applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 10,000 at more than 30 facilities worldwide and generates more than $1.7 billion of annual revenue. For more information, visit www.catalent.com

SOURCE: Catalent Pharma Solutions